News
Federal regulators are asking Novavax to complete an additional clinical trial on its Covid-19 vaccine after previously ...
Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...
Novavax's vaccine has been available since 2022 in the U.S. after the FDA granted its emergency use. "We look forward to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results